PROTAGONIST THERAPEUTICS, INC.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$668M
↓-10.3% -$77Mvs FY2024
Total Liabilities
$53M
↓-23.0% -$16Mvs FY2024
Equity
$615M
↓-9.0% -$61Mvs FY2024
Cash
$128M
↑+32.0% +$31Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $668M | $745M |
| Current Assets | $578M | $592M |
| Cash | $128M | $97M |
| ST Investments | $439M | $322M |
| Receivables | $0 | $0 |
| Inventory | $0 | $0 |
| Other Current | $10M | $173M |
| Non-Current Assets | $91M | $153M |
| PPE | $4M | $3M |
| Goodwill | $0 | $0 |
| Intangibles | $0 | $0 |
| Investments | $79M | $140M |
| Other Non-Current | $8M | $10M |
| Total Liab+Eq | $668M | $745M |
| Current Liab. | $45M | $47M |
| Accounts Payable | $5M | $2M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $0 |
| Other CL | $40M | $46M |
| Non-Current Liab. | $8M | $22M |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $8M | $22M |
| Equity | $615M | $675M |
| Retained Earnings | $471M | $341M |
| Other Equity | $144M | $335M |
QuarterCharts · SEC EDGAR data · PTGX · Comparing FY2025 vs FY2024